PEN Semaglutide 5mg Hilma Biocare

PEN Semaglutide 5mg by Hilma Biocare is a ready-to-use pre-filled pen based on semaglutide, the same active substance found in Ozempic. It belongs to the GLP-1 receptor agonist class and is used for type 2 diabetes management and weight control. It works by stimulating insulin release when glucose rises, curbing excess glucagon and slowing gastric emptying — which together reduce appetite and keep blood sugar stable. The pen format makes precise weekly dosing simple, with no vials or reconstitution.

Effects and benefits

Semaglutide is one of the most effective tools available for appetite control and sustained fat loss. By mimicking the GLP-1 hormone it reduces hunger and cravings, stabilises blood sugar and supports steady, manageable weight reduction when combined with diet.

• Effective appetite and craving control
• Sustained, steady weight loss
• Stabilises blood glucose
• Convenient weekly pen dosing

Usage and administration

Semaglutide is injected subcutaneously once weekly, always starting at a low dose and titrating up slowly to limit nausea. As a GLP-1 agonist it belongs alongside the rest of the metabolic peptides range rather than in a performance cycle.

Related products

Those comparing GLP-1 options often look at the dual-agonist Tirzepatide or the triple-agonist Retatrutide for stronger appetite and metabolic effects.

Why choose Hilma Biocare

Each pen is produced to consistent pharmaceutical standards with dependable dosing you can trust. Explore the full Hilma Biocare catalogue for matching metabolic products.